Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis

FASEB Journal

Volumn 26, Issue 12, 2012, Pages 4937-4950

  Faryna, Marta ^a   Konermann, Carolin ^a,b   Aulmann, Sebastian ^b   Bermejo, Justo Lorenzo ^b   Brugger, Markus ^b   Diederichs, Sven ^a,b   Rom, Joachim ^b   Weichenhan, Dieter ^a   Claus, Rainer ^a,c   Rehli, Michael ^d   Schirmacher, Peter ^b   Sinn, Hans Peter ^b   Plass, Christoph ^a   Gerhauser, Clarissa ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

CpG island array; DMR; Ductal carcinoma in situ; EpiTyper MassArray; Estrogen receptor positive; Methyl CpG immunoprecipitation

Indexed keywords

BIOLOGICAL MARKER; BREVICAN; HOMOEOBOX D1; KRUPPEL LIKE FACTOR 11; NEUREXOPHILIN 1; POTASSIUM CHANNEL TETRAMERIZATION DOMAIN CONTAINING 8; POU CLASS 4 HOMEOBOX 1; PROGESTERONE RECEPTOR; PROTOCADHERIN 10; RYANODINE RECEPTOR 2; SINGLE MINDED HOMOLOG 1; TRANSCRIPTION FACTOR 7 LIKE 1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BREAST NEOPLASMS; BREVICAN; CELL CYCLE PROTEINS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; GLYCOPROTEINS; HOMEODOMAIN PROTEINS; HUMANS; MCF-7 CELLS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEUROPEPTIDES; REPRESSOR PROTEINS; TRANSCRIPTION FACTOR 7-LIKE 1 PROTEIN; TRANSCRIPTION FACTOR BRN-3A; TUMOR MARKERS, BIOLOGICAL;

EID: 84870322656     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-209502     Document Type: Article

References (59)

1. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., and Parkin, D. M. (2010) GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [online], International Agency for Research on Cancer>, Lyon, France, http://globocan.iarc.fr
2. Holleczek, B., Arndt, V., Stegmaier, C., and Brenner, H. (2011) Trends in breast cancer survival in Germany from 1976 to 2008: a period analysis by age and stage. Cancer Epidemiol. 35, 399-406
3. Weigelt, B., and Reis-Filho, J. S. (2009) Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat. Rev. Clin. Oncol. 6, 718-730
4. Vollenweider-Zerargui, L., Barrelet, L., Wong, Y., Lemarchand-Beraud, T., and Gomez, F. (1986) The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients. Cancer 57, 1171-1180 (Pubitemid 16166228)
5. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein Lonning, P., and Borresen-Dale, A. L. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98, 10869-10874 (Pubitemid 32878711)
6. Sorlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., Demeter, J., Perou, C. M., Lonning, P. E., Brown, P. O., Borresen-Dale, A. L., and Botstein, D. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U. S. A. 100, 8418-8423 (Pubitemid 36842560)
7. Esteller, M. (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8, 286-298
8. Jones, P. A., and Baylin, S. B. (2007) The epigenomics of cancer. Cell 128, 683-692 (Pubitemid 46273572)
9. Portela, A., and Esteller, M. (2010) Epigenetic modifications and human disease. Nat. Biotechnol. 28, 1057-1068
10. Feinberg, A. P., Ohlsson, R., and Henikoff, S. (2006) The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7, 21-33 (Pubitemid 41828945)
11. Widschwendter, M., and Jones, P. A. (2002) DNA methylation and breast carcinogenesis. Oncogene 21, 5462-5482 (Pubitemid 34983482)
12. Ordway, J. M., Budiman, M. A., Korshunova, Y., Maloney, R. K., Bedell, J. A., Citek, R. W., Bacher, B., Peterson, S., Rohlfing, T., Hall, J., Brown, R., Lakey, N., Doerge, R. W., Martienssen, R. A., Leon, J., McPherson, J. D., and Jeddeloh, J. A. (2007) Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS One 2, e1314
13. Huang, Y., Nayak, S., Jankowitz, R., Davidson, N. E., and Oesterreich, S. (2011) Epigenetics in breast cancer: what's new? Breast Cancer Res. 13, 225
14. Dedeurwaerder, S., Fumagalli, D., and Fuks, F. (2011) Unravelling the epigenomic dimension of breast cancers. Curr. Opin. Oncol. 23, 559-565
15. Tommasi, S., Karm, D. L., Wu, X., Yen, Y., and Pfeifer, G. P. (2009) Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res. 11, R14
16. Killian, J. K., Bilke, S., Davis, S., Walker, R. L., Jaeger, E., Killian, M. S., Waterfall, J. J., Bibikova, M., Fan, J. B., Smith, W. I., Jr., and Meltzer, P. S. (2011) A methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology. Am. J. Pathol. 179, 55-65
17. Li, L., Lee, K. M., Han, W., Choi, J. Y., Lee, J. Y., Kang, G. H., Park, S. K., Noh, D. Y., Yoo, K. Y., and Kang, D. (2010) Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer. Hum. Mol. Genet. 19, 4273-4277
18. Fackler, M. J., Umbricht, C. B., Williams, D., Argani, P., Cruz, L. A., Merino, V. F., Teo, W. W., Zhang, Z., Huang, P., Visvananthan, K., Marks, J., Ethier, S., Gray, J. W., Wolff, A. C., Cope, L. M., and Sukumar, S. (2011) Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 71, 6195-6207
19. Hill, V. K., Ricketts, C., Bieche, I., Vacher, S., Gentle, D., Lewis, C., Maher, E. R., and Latif, F. (2011) Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res. 71, 2988-2999
20. Van der Auwera, I., Yu, W., Suo, L., Van Neste, L., van Dam, P., Van Marck, E. A., Pauwels, P., Vermeulen, P. B., Dirix, L. Y., and Van Laere, S. J. Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One 5, e12616
21. Holm, K., Hegardt, C., Staaf, J., Vallon-Christersson, J., Jonsson, G., Olsson, H., Borg, A., and Ringner, M. (2010) Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. Breast Cancer Res. 12, R36
22. Bediaga, N. G., Acha-Sagredo, A., Guerra, I., Viguri, A., Albaina, C., Ruiz Diaz, I., Rezola, R., Alberdi, M. J., Dopazo, J., Montaner, D., de Renobales, M., Fernandez, A. F., Field, J. K., Fraga, M. F., Liloglou, T., and de Pancorbo, M. M. (2010) DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer Res. 12, R77
23. Dedeurwaerder, S., Desmedt, C., Calonne, E., Singha, S. K., Haibe-Kains, B., Defrance, M., Michiels, S., Volkmar, M., Deplus, R., Luciani, J., Lallemand, F., Larsimont, D., Toussaint, J., Haussy, S., Rothe, F., Rouas, G., Metzger, O., Majjaj, S., Saini, K., Putmans, P., Hames, G., Baren, N. V., Coulie, P. G., Piccart, M., Sotiriou, C., and Fuks, F. (2011) DNA methylation profiling reveals a predominant immune component in breast cancers. EMBO Mol. Med. 3, 726-741
24. Flanagan, J. M., Cocciardi, S., Waddell, N., Johnstone, C. N., Marsh, A., Henderson, S., Simpson, P., da Silva, L., Khanna, K., Lakhani, S., Boshoff, C., and Chenevix-Trench, G. (2010) DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. Am. J. Hum. Genet. 86, 420-433
25. Fang, F., Turcan, S., Rimner, A., Kaufman, A., Giri, D., Morris, L. G., Shen, R., Seshan, V., Mo, Q., Heguy, A., Baylin, S. B., Ahuja, N., Viale, A., Massague, J., Norton, L., Vahdat, L. T., Moynahan, M. E., and Chan, T. A. (2011) Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci. Transl. Med. 3, 75ra25
26. Gebhard, C., Schwarzfischer, L., Pham, T. H., Schilling, E., Klug, M., Andreesen, R., and Rehli, M. (2006) Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res. 66, 6118-6128
27. Schilling, E., and Rehli, M. (2007) Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics 90, 314-323 (Pubitemid 47176332)
28. Rauch, T. A., Zhong, X., Wu, X., Wang, M., Kernstine, K. H., Wang, Z., Riggs, A. D., and Pfeifer, G. P. (2008) High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc. Natl. Acad. Sci. U. S. A. 105, 252-257
29. Schilling, E., El Chartouni, C., and Rehli, M. (2009) Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences. Genome Res. 19, 2028-2035
30. Huang, D. W., Sherman, B. T., and Lempicki, R. A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13
31. Huang, D. W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
32. Edgar, R., Domrachev, M., and Lash, A. E. (2002) Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210 (Pubitemid 34679544)
33. Ehrich, M., Nelson, M. R., Stanssens, P., Zabeau, M., Liloglou, T., Xinarianos, G., Cantor, C. R., Field, J. K., and van den Boom, D. (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 102, 15785-15790 (Pubitemid 41552820)
34. Goeppert, B., Schmezer, P., Dutruel, C., Oakes, C., Renner, M., Breinig, M., Warth, A., Vogel, M. N., Mittelbronn, M., Mehrabi, A., Gdynia, G., Penzel, R., Longerich, T., Breuhahn, K., Popanda, O., Plass, C., Schirmacher, P., and Kern, M. A. (2010) Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 52, 2023-2033
35. Narayan, G., Freddy, A. J., Xie, D., Liyanage, H., Clark, L., Kisselev, S., Un Kang, J., Nandula, S. V., McGuinn, C., Subramaniyam, S., Alobeid, B., Satwani, P., Savage, D., Bhagat, G., and Murty, V. V. (2011) Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance. Genes Chromosomes Cancer 50, 1043-1053
36. Yu, J., Cheng, Y. Y., Tao, Q., Cheung, K. F., Lam, C. N., Geng, H., Tian, L. W., Wong, Y. P., Tong, J. H., Ying, J. M., Jin, H., To, K. F., Chan, F. K., and Sung, J. J. (2009) Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 136, 640-651 e641
37. Narayan, G., Scotto, L., Neelakantan, V., Kottoor, S. H., Wong, A. H., Loke, S. L., Mansukhani, M., Pothuri, B., Wright, J. D., Kaufmann, A. M., Schneider, A., Arias-Pulido, H., Tao, Q., and Murty, V. V. (2009) Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes Chromosomes Cancer 48, 983-992
38. UCSC Genome Browser Track Data Hub: Roadmap Epigenomics Data Complete Collection at Washington University in St. Louis, Assembly hg19, accessed August 2012 at http://vizhub.wustl.edu/VizHub/RoadmapReleaseAll.txt
39. Novak, P., Jensen, T., Oshiro, M. M., Watts, G. S., Kim, C. J., and Futscher, B. W. (2008) Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res. 68, 8616-8625
40. Kamalakaran, S., Varadan, V., Giercksky Russnes, H. E., Levy, D., Kendall, J., Janevski, A., Riggs, M., Banerjee, N., Synnestvedt, M., Schlichting, E., Karesen, R., Shama Prasada, K., Rotti, H., Rao, R., Rao, L., Eric Tang, M. H., Satyamoorthy, K., Lucito, R., Wigler, M., Dimitrova, N., Naume, B., Borresen-Dale, A. L., and Hicks, J. B. (2011) DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Mol. Oncol. 5, 77-92
41. Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A., Marks, J., and Sukumar, S. (2001) Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 20, 3348-3353 (Pubitemid 32588983)
42. Lehmann, U., Langer, F., Feist, H., Glockner, S., Hasemeier, B., and Kreipe, H. (2002) Quantitative assessment of promoter hypermethylation during breast cancer development. Am. J. Pathol. 160, 605-612 (Pubitemid 34160338)
43. Fackler, M. J., McVeigh, M., Evron, E., Garrett, E., Mehrotra, J., Polyak, K., Sukumar, S., and Argani, P. (2003) DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int. J. Cancer 107, 970-975 (Pubitemid 37429839)
44. Lee, J. S. (2007) GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Arch. 450, 637-642
45. Pasquali, L., Bedeir, A., Ringquist, S., Styche, A., Bhargava, R., and Trucco, G. (2007) Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma. Cancer Lett. 257, 136-144 (Pubitemid 47464705)
46. Hoque, M. O., Prencipe, M., Poeta, M. L., Barbano, R., Valori, V. M., Copetti, M., Gallo, A. P., Brait, M., Maiello, E., Apicella, A., Rossiello, R., Zito, F., Stefania, T., Paradiso, A., Carella, M., Dallapiccola, B., Murgo, R., Carosi, I., Bisceglia, M., Fazio, V. M., Sidransky, D., and Parrella, P. (2009) Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol. Biomarkers Prev. 18, 2694-2700
47. Muggerud, A. A., Ronneberg, J. A., Warnberg, F., Botling, J., Busato, F., Jovanovic, J., Solvang, H., Bukholm, I., Borresen-Dale, A. L., Kristensen, V. N., Sorlie, T., and Tost, J. (2010) Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res. 12, R3
48. Moelans, C. B., Verschuur-Maes, A. H., and van Diest, P. J. (2011) Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer J. Pathol. 225, 222-231
49. Park, S. Y., Kwon, H. J., Lee, H. E., Ryu, H. S., Kim, S. W., Kim, J. H., Kim, I. A., Jung, N., Cho, N. Y., and Kang, G. H. (2011) Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch. 458, 73-84
50. Ying, J., Li, H., Seng, T. J., Langford, C., Srivastava, G., Tsao, S. W., Putti, T., Murray, P., Chan, A. T., and Tao, Q. (2006) Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25, 1070-1080 (Pubitemid 43277014)
51. Deli, T., Varga, N., Adam, A., Kenessey, I., Raso, E., Puskas, L. G., Tovari, J., Fodor, J., Feher, M., Szigeti, G. P., Csernoch, L., and Timar, J. (2007) Functional genomics of calcium channels in human melanoma cells. Int. J. Cancer 121, 55-65 (Pubitemid 46753851)
52. Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., and Laird, P. W. (2007) Epigenetic stem cell signature in cancer Nat. Genet. 39, 157-158 (Pubitemid 46184343)
53. Ohm, J. E., and Baylin, S. B. (2007) Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell Cycle 6, 1040-1043 (Pubitemid 46708576)
54. Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., Chevalier, B., Johnstone, S. E., Cole, M. F., Isono, K., Koseki, H., Fuchikami, T., Abe, K., Murray, H. L., Zucker, J. P., Yuan, B., Bell, G. W., Herbolsheimer, E., Hannett, N. M., Sun, K., Odom, D. T., Otte, A. P., Volkert, T. L., Bartel, D. P., Melton, D. A., Gifford, D. K., Jaenisch, R., and Young, R. A. (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125, 301-313 (Pubitemid 44313811)
55. Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., Berman, D. M., Jenuwein, T., Pruitt, K., Sharkis, S. J., Watkins, D. N., Herman, J. G., and Baylin, S. B. (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39, 237-242
56. Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., Bergman, Y., Simon, I., and Cedar, H. (2007) Polycomb-mediated methylation on Lys27 of histone H3 premarks genes for de novo methylation in cancer. Nat. Genet. 39, 232-236 (Pubitemid 46184355)
57. Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G., Otte, A. P., Hayes, D. F., Sabel, M. S., Livant, D., Weiss, S. J., Rubin, M. A., and Chinnaiyan, A. M. (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 100, 11606-11611 (Pubitemid 37205983)
58. Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J. M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., and Fuks, F. (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874 (Pubitemid 43255707)
59. Kondo, Y., Shen, L., Cheng, A. S., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi-Addo, B., Gold, D. L., Sekido, Y., Huang, T. H., and Issa, J. P. (2008) Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40, 741-750 (Pubitemid 351748874)